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Abstract. A ‘Rapid Recommendation’ has been produced by the GRADE group, in 
collaboration with MAGIC and BMJ, in response to an RCT showing Dual Anti-
Platelet Therapy (DAPT) is superior to Aspirin alone for patients who had suffered 
acute high risk transient ischaemic attack or minor ischaemic stroke. The interactive 
MAGIC decision aid that accompanies each Rapid Recommendation is the main 
route to their clinical implementation. It can facilitate preference-sensitive person-
centred care, but only if a Multi-Criteria Decision Analysis-based decision support 
tool is added. A demonstration version of such an add-on to the MAGIC aid, divested 
of recommendations, is available online. Exploring the results of different preference 
inputs into the tool raises questions about the strong recommendation for DAPT. 
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Introduction 
 
A ‘Rapid Recommendation’ has been produced by the GRADE group, in collaboration 
with MAGIC and BMJ [1], in response to an RCT showing Dual Anti-Platelet Therapy 
(Clopidogrel and Aspirin) (DAPT) was superior to Aspirin monotherapy for patients who 
have suffered acute high risk transient ischaemic attack or minor ischaemic stroke [2].  
 
In the systematic review and meta-analysis undertaken as part of the Rapid 
Recommendation production process [3], it was confirmed that DAPT was not a 
dominant option, i.e. it was not best or equal best on all criteria. The Rapid 
Recommendation was nevertheless  a ‘strong’ one in favour of DAPT, to be started 
within 24 hours in patients who have had a high risk transient ischaemic attack or minor 
stroke and to be continued for 10-21 days, at which point patients should continue with 
aspirin alone. In GRADE ‘Strong recommendations mean that most informed patients 
would choose the recommended management and that clinicians can structure their 
interactions with patients accordingly.’ [4] (p1051, italics supplied). 
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When there is no dominant option any recommendation is necessarily preference-
sensitive, reflecting the relative importance weights assigned to the various criteria. The 
preferences elicited in the GRADE study were those of the guidelines panel: 
… the patient-important outcomes were defined by an international guideline 
panel [of 19 persons, which] judged death, non-fatal stroke, major extracranial 
bleeding, functional ability, and quality of life as critical outcomes. Myocardial 
infarction, recurrent transient ischaemic attack, and minor extracranial bleeding 
were judged less important [1]. (p.3). 
In person-centred care that meets the requirements for informed consent the relevant 
preferences are those of the individual patient elicited at the point of care. These may be 
out of line with the average ones reflected in the recommendation of a guideline panel.   
 
Method 
 
We introduce an add-on to the interactive online MAGIC decision aid, presented as the 
main route to clinical implementation of the rapid recommendation. The add-on enables 
the criteria importance weights to be varied, to produce a personalised opinion available 
at the point of decision. It transforms the aid from being simply a set of excellent - but 
cognitively challenging - infographics, for example Figure 1, into a personalised 
preference-sensitive decision support tool. 
 
 
 
Figure 1. Infographic in MAGIC aid [https://www.bmj.com/content/363/bmj.k5130] 
 
The basic inputs into the decision support tool are the seven featured criteria in the 
MAGIC decision aid, along with the evidence on how DAPT and ASPIRIN perform on 
them, as their Ratings. A treatment burden criterion is added, for which the individual is 
asked to supply their personal difficulty ratings, based on the ‘Practical Considerations’ 
section of the aid. Most significantly, they provide their percentage importance 
Weightings for the eight criteria. The Weightings and Ratings are integrated in expected 
value calculations to generate a preference-sensitive opinion - pair of Option Scores - for 
the person to discuss (Figure 2). Having seen these scores they then have the opportunity 
to revise their Weightings in the light of the displayed Ratings. The tool is built in the 
Annalisa implementation of Multi-Criteria Decision Analysis (MCDA) [5]. 
 
GRADE use four verbal levels to classify the quality ('certainty') of the evidence. In 
our conception of a decision support tool, adjusting for this is not a task to be left outside 
the tool for 'consideration'. MCDA requires quantitative inputs, so the levels are here 
mapped as Very low = 0.1; Low = 0.4; Moderate = 0.7; High = 1.0. Certainty-adjusted 
scores are thereby also calculated and displayed as a second pair in the interface. 
 
Result 
 
To engage with the tool, on a demonstration-only basis, go to https://ale.rsyd.dk and enter 
1499 as survey ID.  A sample output screen appears in Figure 2.  
 
 
 
Figure 2. Screen capture from decision support tool 
 
The criterion importance weightings in the figure are in line with those of the 
guideline panel but they actually produce an opinion favouring aspirin monotherapy, 
albeit at the third decimal place. But such near-equipoise is produced by many sets of 
weightings and it remains after certainty adjustment. (These results are best confirmed 
by engaging with aid.) The strong recommendation for DAPT is therefore very 
surprising, since for GRADE this makes option discussion with the patient unnecessary. 
 
Discussion 
 
In addition to wider concerns regarding GRADE [6] 
It is difficult to personalise recommendations from guidelines … Usable 
decision aids should now be seen as one of the most important end products for 
evidence based medicine. [7] (pp1-2). 
However the well-established difficulties arising in attempts to  introduce decision aids 
into clinical practice need to be recognised [8].  
 
Conclusion 
 
In keeping with that of GRADE, MAGIC, and the BMJ, the aim is to provide support 
for more transparent and accountable clinical decisions, made within typical time and 
practice constraints and cognitive limitations of all parties. Person-centred care involves 
serious elicitation of individual’s preferences at the point of care - as provided for in this 
add-on aid. The resulting opinion may legitimately deviate from expert-based guidelines. 
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